Boenning & Scattergood’s Organon & Co OGN Stock Holding History

Boenning & Scattergood’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-6,960	Closed	-$235K	–	382
2022 Q2	$235K	Buy	+6,960	New	+$244K	0.04%	334

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Boenning & Scattergood's OGN Position: Q3 2022 in Review

Boenning & Scattergood sold out of Organon & Co (OGN) in Q3 2022, closing a stake of 6,960 shares — an estimated $235K sold.

Boenning & Scattergood first reported a position in OGN in Q2 2022 and held it in 1 quarter. The position peaked at $235K in Q2 2022. 791 funds tracked by Wall St. Rank hold OGN as of Q3 2022.

Boenning & Scattergood reported no remaining Organon & Co position as of Q3 2022 after selling out during the quarter.
Boenning & Scattergood sold 6,960 Organon & Co shares in Q3 2022, an estimated $235K.
Boenning & Scattergood first reported a position in Organon & Co in Q2 2022 and held it in 1 quarter.
Boenning & Scattergood's Organon & Co position peaked at $235K in Q2 2022.
791 funds tracked by Wall St. Rank held Organon & Co as of Q3 2022.

Based on Boenning & Scattergood's 13F filing for Q3 2022, filed 11 Oct 2022.